Real-World Efficacy Data and Predictive Clinical Parameters for Treatment Outcomes in Advanced Esophageal Squamous Cell Carcinoma Treated with Immune Checkpoint Inhibitors

PURPOSE: This study aimed to evaluate the real-world efficacy of immune checkpoint inhibitors (ICIs), and to identify clinicolaboratory factors to predict treatment outcomes in patients with advanced esophageal squamous cell carcinoma (ESCC) receiving ICIs. MATERIALS AND METHODS: Sixty patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jwa Hoon, Ahn, Bokyung, Hong, Seung-Mo, Jung, Hwoon-Yong, Kim, Do Hoon, Choi, Kee Don, Ahn, Ji Yong, Lee, Jeong Hoon, Na, Hee Kyoung, Kim, Jong Hoon, Kim, Yong-Hee, Kim, Hyeong Ryul, Lee, Hyun Joo, Kim, Sung-Bae, Park, Sook Ryun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016310/
https://www.ncbi.nlm.nih.gov/pubmed/34176250
http://dx.doi.org/10.4143/crt.2020.1198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016310/
https://www.ncbi.nlm.nih.gov/pubmed/34176250
http://dx.doi.org/10.4143/crt.2020.1198

Ejemplares similares